Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HearAtLast Group was a healthcare services company that specialized in the audiology sector, primarily focusing on the retail sale of hearing aids and related diagnostic services. The company's core business strategy involved establishing professional hearing clinics within high-traffic retail environments, most notably through a long-standing partnership with Walmart Canada. These clinics provided customers with access to licensed audiologists, hearing tests, and a variety of hearing aid technologies from major manufacturers. By positioning clinics in accessible retail locations, HearAtLast aimed to lower the barriers to hearing care and provide more affordable options for the aging population. The company was publicly traded on the OTC markets under the symbol HRAL. In later years, the company faced financial challenges and eventually transitioned its corporate structure, leading to a pivot away from its original clinical hearing aid business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HearAtLast Group.